How does cocaine cause priapism and what emergency treatments are recommended?
Executive summary
Cocaine-associated priapism is an uncommon but serious form of ischemic (low‑flow) priapism in which cocaine’s effects on sympathetic and monoaminergic signaling appear to disrupt normal detumescence, producing a prolonged, painful erection that is a urologic emergency [1] [2]. Emergency management follows standard ischemic‑priapism steps—analgesia, aspiration/irrigation of the corpora cavernosa and intracavernosal sympathomimetics such as phenylephrine or epinephrine—with more invasive shunting or surgical options reserved for refractory cases; delays in presentation and treatment worsen outcomes [3] [4] [5] [6].
1. How cocaine is thought to trigger priapism: sympathetic depletion and monoamine effects
The dominant hypotheses emerging from case series and mechanistic studies propose two overlapping pathways: chronic or acute cocaine exposure can deplete norepinephrine from sympathetic nerve terminals or otherwise impair adrenergic regulation of cavernous smooth muscle, removing the sympathetic “off” signal required for detumescence and favoring veno‑occlusion and ischemia [7] [5]. Parallel or alternative mechanisms implicate cocaine’s effects on serotonin reuptake—raising local serotonin levels that may provoke vasodilation and impair venous outflow—and interactions with other drugs (for example phosphodiesterase inhibitors or trazodone) that further disturb penile hemodynamics [1] [8].
2. Clinical phenotype: ischemic (low‑flow) presentation and the time‑sensitive nature
The vast majority of drug‑related priapism presentations are ischemic, characterized by painful, rigid erections with hypoxic, acidotic corporal blood that can rapidly progress to tissue necrosis and permanent erectile dysfunction if not reversed promptly; this defines it as an emergency in standard guidelines [2] [3] [9]. Case series and systematic reviews report that patients with cocaine‑related priapism often present late—mean times around 36–43 hours in some reports—which correlates with need for more procedures and worse prognosis [10] [6] [1].
3. First‑line emergency measures: evaluation, analgesia, and differentiating ischemic vs nonischemic
Initial ED evaluation aims to confirm ischemic priapism using history, physical exam and, when available, corporal blood gas testing; analgesia is important because ischemic priapism is painful and may impair cooperation with procedures [3] [2]. Differentiating high‑flow (nonischemic) priapism—which is usually painless and often nonurgent—from ischemic priapism guides urgency because treatment protocols differ markedly [3].
4. Stepwise treatment: aspiration, irrigation, and intracavernosal sympathomimetics
Standard ischemic‑priapism therapy proceeds stepwise: corporal aspiration of stagnant blood and irrigation with normal or heparinized saline to restore flow, followed by intracavernosal injection of a concentrated alpha‑adrenergic agonist—most commonly phenylephrine—administered in repeated diluted boluses while monitoring vitals [3] [5]. Emergency literature and cases document successful use of intracavernosal epinephrine, sometimes without aspiration, as a minimally invasive alternative in select settings and specifically report success in cocaine‑related cases [4].
5. Refractory cases: shunting, surgical management, and prognosis
When aspiration and intracavernosal sympathomimetics fail, urologic options escalate to distal or proximal shunting procedures (e.g., Winter or Morey shunts) and, rarely, penile prosthesis placement for irreversible tissue damage; cocaine‑associated episodes have been reported to be more refractory, requiring multiple procedures and carrying higher risk of long‑term erectile dysfunction if treatment is delayed [5] [6] [1]. The literature stresses early presentation—ideally within hours—to maximize chance of detumescence with less invasive measures and preserve erectile function [2] [6].
6. Limits of current evidence and practical takeaways
Evidence about cocaine‑specific mechanisms and outcomes is largely case reports, small series, and a recent systematic review; larger prospective data are lacking, so mechanistic models (sympathetic norepinephrine depletion versus serotonin effects) remain plausible but not definitively proven [7] [1] [6]. Clinically, the actionable conclusions are firm in the sources: treat suspected ischemic priapism urgently using aspiration/irrigation and intracavernosal alpha‑agonists, involve urology early for refractory cases, and recognize that co‑ingestion of other erectile or psychotropic agents and delayed presentation worsen prognosis [3] [4] [8] [11].